Alternation in circARF3 (ADP-ribosylation Factor 3) and its Target Gene miR-103 Activity Promotes Hepatocellular Carcinoma in Obese Patients with Metabolic-Associated Fatty Liver - Egyptian Knowledge Bank

279213

Alternation in circARF3 (ADP-ribosylation Factor 3) and its Target Gene miR-103 Activity Promotes Hepatocellular Carcinoma in Obese Patients with Metabolic-Associated Fatty Liver

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Alteration of metabolic genes in peripheral blood isolated from patients with acute myocardial infarction

Article

Expression of MicroRNA-24 in Aflatoxin B1 Exposed Patients with Hepatocellular Carcinoma and Cirrhosis

Article

Alterations in microRNA-15a and “γ-synuclein” Expression Levels Among HCV-Related Hepatocellular Carcinoma Patients in Egypt.

Article

MicroRNA 122 as adiagnostic biomarker for hepatitis C- related hepatocellular carcinoma

Article

Downregulation of miR-23a and miR-24 in human hepatocellular carcinoma cells by Sorafenib via transforming growth factor-beta 1 in a SMAD dependent manner

Article

Alterations of Some MicroRNAs Expression in Hepatocellular Carcinoma Cell Lines by Sodium Butyrate

Article

TLR2 Gene Polymorphism and MicroRNA 301 gene Expression Level as a Signature for Hepatocellular Carcinoma in Egyptian Patients

Article

Progressive and Prognosis Role of Lipogenic Pathway in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Article

Micro RNA 155 and Its Target Gene CTLA4 As a New Biomarker for Lymphocyte ‎Activation in HCV-Induced Liver Fibrosis and Hepatocellular Carcinoma

Article

Molecular Insights into The Biological Basis of Anticancer Efficacy of miRNA Suppression Therapy in HCC Cell Lines